191 related articles for article (PubMed ID: 2410574)
41. A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up.
Levi JA; Thomson D; Sandeman T; Tattersall M; Raghavan D; Byrne M; Gill G; Harvey V; Burns I; Snyder R
J Clin Oncol; 1988 Jul; 6(7):1154-60. PubMed ID: 2455778
[TBL] [Abstract][Full Text] [Related]
42. Treatment of childhood germ cell tumors. Review of the St. Jude experience from 1979 to 1988.
Marina N; Fontanesi J; Kun L; Rao B; Jenkins JJ; Thompson EI; Etcubanas E
Cancer; 1992 Nov; 70(10):2568-75. PubMed ID: 1384951
[TBL] [Abstract][Full Text] [Related]
43. Preservation of retroperitoneal lymph nodes in patients with locoregional nonseminomatous germ cell tumors: surveillance and primary chemotherapy.
von Eschenbach AC; Swanson DA; Johnson DE; Wishnow KI; Stephenson RA; Babaian RJ
Prog Clin Biol Res; 1991; 370():385-92. PubMed ID: 1718009
[No Abstract] [Full Text] [Related]
44. [Non-testicular germ cell tumors: analysis of the therapy study MAKEI 83/86 anc changes in the protocol for the follow-up study].
Göbel U; Bamberg M; Haas RJ; Bökkerink JP; Brämswig G; Calaminus G; Engert J; Gadner H; Havers W; Janka-Schaub GE
Klin Padiatr; 1989; 201(4):247-60. PubMed ID: 2476583
[TBL] [Abstract][Full Text] [Related]
45. [Treatment outcome on 52 patients with 53 testicular germ cell tumors].
Yokoyama M; Nemoto K; Kanemura M; Kitahara K; Oda H; Murata H; Matsunaga Y
Hinyokika Kiyo; 1998 Nov; 44(11):789-94. PubMed ID: 9893223
[TBL] [Abstract][Full Text] [Related]
46. Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients.
Mencel PJ; Motzer RJ; Mazumdar M; Vlamis V; Bajorin DF; Bosl GJ
J Clin Oncol; 1994 Jan; 12(1):120-6. PubMed ID: 7505805
[TBL] [Abstract][Full Text] [Related]
47. VAB-6 combination chemotherapy without maintenance in treatment of disseminated cancer of the testis.
Vugrin D; Whitmore WF; Golbey RB
Cancer; 1983 Jan; 51(2):211-5. PubMed ID: 6185197
[TBL] [Abstract][Full Text] [Related]
48. Chemotherapy of disseminated testicular cancer.
Einhorn LH
Acta Urol Belg; 1985; 53(2):411-27. PubMed ID: 2409784
[No Abstract] [Full Text] [Related]
49. Effect of treatment on fertility and sexual function in males with metastatic nonseminomatous germ cell tumors of testis.
Brenner J; Vugrin D; Whitmore WF
Am J Clin Oncol; 1985 Apr; 8(2):178-82. PubMed ID: 2422920
[TBL] [Abstract][Full Text] [Related]
50. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
[TBL] [Abstract][Full Text] [Related]
51. [Treatment of nonseminomatous testicular tumor with liver metastases].
Masuda F; Nakada J; Kondo N; Takahashi T; Mochizuki A; Iizuka N
Hinyokika Kiyo; 1988 Feb; 34(2):351-5. PubMed ID: 2454020
[TBL] [Abstract][Full Text] [Related]
52. [Management of advanced seminoma: retrospective study of 96 patients].
Bompas E; Fléchon A; Biron P; Droz JP
Bull Cancer; 2002 Oct; 89(10):877-85. PubMed ID: 12441279
[TBL] [Abstract][Full Text] [Related]
53. Chemotherapy of refractory germ cell cancer with Etoposide.
Lederman GS; Garnick MB; Canellos GP; Richie JP
J Clin Oncol; 1983 Nov; 1(11):706-9. PubMed ID: 6321675
[TBL] [Abstract][Full Text] [Related]
54. Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience.
Motzer RJ; Bajorin DF; Vlamis V; Weisen S; Bosl GJ
Semin Oncol; 1992 Dec; 19(6 Suppl 12):8-11. PubMed ID: 1336624
[TBL] [Abstract][Full Text] [Related]
55. Treatment outcome of patients with extragonadal nonseminomatous germ cell tumors: the Saitama Cancer Center experience.
Fukui N; Kohno Y; Ishioka J; Fukuda H; Kageyama Y; Higashi Y
Int J Clin Oncol; 2013 Aug; 18(4):731-4. PubMed ID: 22763659
[TBL] [Abstract][Full Text] [Related]
56. Treatment of favorable-prognosis nonseminomatous testicular germ cell tumors with etoposide, cisplatin, and reduced dose of bleomycin.
Brada M; Horwich A; Peckham MJ
Cancer Treat Rep; 1987 Jun; 71(6):655-6. PubMed ID: 2438041
[TBL] [Abstract][Full Text] [Related]
57. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U
Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864
[TBL] [Abstract][Full Text] [Related]
58. Neoadjuvant chemotherapy for newly diagnosed germ-cell tumors of the central nervous system.
Allen JC; Kim JH; Packer RJ
J Neurosurg; 1987 Jul; 67(1):65-70. PubMed ID: 2439668
[TBL] [Abstract][Full Text] [Related]
59. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
60. Primary chemotherapy and the role of second-look laparotomy in non-dysgerminomatous germ cell malignancies of the ovary.
Pippitt CH; Cain JM; Hakes TB; Pierce VK; Lewis JL
Gynecol Oncol; 1988 Oct; 31(2):268-75. PubMed ID: 2458993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
